We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+0.69%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$1.44B
AUM Growth
-$465M
Cap. Flow
-$442M
Cap. Flow %
-30.7%
Top 10 Hldgs %
11.9%
Holding
1,595
New
313
Increased
337
Reduced
470
Closed
413

Sector Composition

Rank Sector Weight
1 Technology 17.01%
2 Healthcare 10.93%
3 Consumer Discretionary 9.87%
4 Industrials 9.31%
5 Financials 6.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MPAA icon
1101
Motorcar Parts of America
MPAA
$258M
$98.3K 0.01%
+15,938
New +$91.5K
XPEV icon
1102
XPeng
XPEV
$11.6B
$95.3K 0.01%
+13,000
New +$103K
XFOR icon
1103
X4 Pharmaceuticals
XFOR
$460M
$94.8K 0.01%
+5,446
New +$178K
CTKB icon
1104
Cytek Biosciences
CTKB
$546M
$94.4K 0.01%
16,914
+1,114
+7% +$6.69K
CLNE icon
1105
Clean Energy Fuels
CLNE
$346M
$92.8K 0.01%
+34,754
New +$89.6K
OPAL icon
1106
OPAL Fuels
OPAL
$70.7M
$92.2K 0.01%
22,532
+8,572
+61% +$40.3K
AMPL icon
1107
Amplitude
AMPL
$1.41B
$91.7K 0.01%
10,300
-6,472
-39% -$60.8K
PLCE icon
1108
Children's Place
PLCE
$59.8M
$90.7K 0.01%
11,139
+812
+8% +$7.7K
BORR
1109
Borr Drilling
BORR
$1.19B
$90.6K 0.01%
14,042
+1,998
+17% +$12.1K
EOSE icon
1110
Eos Energy Enterprises
EOSE
$1.51B
$90.2K 0.01%
71,059
+40,646
+134% +$33.6K
NSLR
1111
Neostellar Capital Corp
NSLR
$254M
$88.2K 0.01%
22,000
STRO icon
1112
Sutro Biopharma
STRO
$421M
$87.9K 0.01%
2,999
+1,913
+176% +$75.6K
SLQT icon
1113
SelectQuote
SLQT
$121M
$86.7K 0.01%
31,408
-5,617
-15% -$13.5K
AIOT
1114
PowerFleet Inc
AIOT
$592M
$86.7K 0.01%
18,964
-2,331
-11% -$11.1K
BBCP icon
1115
Concrete Pumping Holdings
BBCP
$491M
$85.5K 0.01%
+14,227
New +$98.2K
MAPS
1116
DELISTED
WM TECHNOLOGY INC A
MAPS
$85.3K 0.01%
81,977
+21,132
+35% +$23.2K
ANTX icon
1117
AN2 Therapeutics
ANTX
$214M
$83.7K 0.01%
38,918
-1,382
-3% -$3.29K
STIM icon
1118
Neuronetics
STIM
$166M
$83.2K 0.01%
46,219
-308
-0.7% -$888
ASPS icon
1119
Altisource Portfolio Solutions
ASPS
$65.8M
$82.7K 0.01%
7,332
-22,692
-76% -$315K
CRON
1120
Cronos Group
CRON
$1.14B
$82.2K 0.01%
35,275
+21,108
+149% +$54.4K
RLGT icon
1121
Radiant Logistics
RLGT
$395M
$80.2K 0.01%
14,100
+3,300
+31% +$17.2K
ADV icon
1122
Advantage Solutions
ADV
$361M
$79.6K 0.01%
989
-464
-32% -$43.2K
IRWD icon
1123
Ironwood Pharmaceuticals
IRWD
$714M
$78.2K 0.01%
11,992
-10,407
-46% -$73.6K
BLZE icon
1124
Backblaze
BLZE
$1.16B
$77.6K 0.01%
+12,592
New +$98.2K
OIS icon
1125
Oil States International
OIS
$491M
$77.3K 0.01%
17,400
-9,500
-35% -$45.7K

Similar funds

Prelude Capital Management's Q2 2024 Portfolio in Review

As of Q2 2024, Prelude Capital Management held 1,595 positions worth $1.44B, down 24% from $1.91B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Prelude Capital Management withdrew a net $442M in Q2 2024, closing 413 positions and reducing 470 holdings. Its most notable exit was Pioneer Natural Resource Co., an estimated $16.5M position sold in full.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Prelude Capital Management opened a new position in Constellation Energy worth $6.37M.

  • Prelude Capital Management's largest Q2 2024 buy was Constellation Energy: 31,786 shares worth $6.37M.
  • Prelude Capital Management added most to Cerevel Therapeutics Holdings, Inc. Common Stock in Q2 2024, an estimated $6.05M increase.
  • Prelude Capital Management's biggest Q2 2024 reduction was NVIDIA, cutting an estimated $13.1M.
  • Prelude Capital Management fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $16.5M.
  • Prelude Capital Management's ten largest holdings make up 12% of its $1.44B portfolio in Q2 2024.
  • Prelude Capital Management opened 313 new positions and closed 413 in Q2 2024.
  • Prelude Capital Management's portfolio value fell 24% quarter-over-quarter to $1.44B.

Based on Prelude Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.